Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Stem cell-based therapies for ischemic stroke: a systematic review and meta-analysis of clinical trials

Fig. 3

Forest plot of mRS comparing the stem cell group and the control group for RCTs and NRSs. a Participants in the stem cell group had a trend beneficial effect in RCTs (MD − 0.41, 95% CI − 0.82 to − 0.00, I2 = 67%). b Participants in stem cell group had no beneficial effect in NRSs (MD − 0.81, 95% CI − 0.68 to 0.32, I2 = 0%)

Back to article page